Risk factors for febrile neutropenia in patients receiving docetaxel chemotherapy for castration-resistant prostate cancer.
about
Score of liver ultrasonography predicts treatment-related severe neutropenia and neutropenic fever in induction chemotherapy with docetaxel for locally advanced head and neck cancer patients with normal serum transamines.Risk of febrile neutropenia and early treatment cessation in men receiving standard and dose-reduced 3-weekly docetaxel for metastatic castration-resistant prostate cancer.
P2860
Risk factors for febrile neutropenia in patients receiving docetaxel chemotherapy for castration-resistant prostate cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Risk factors for febrile neutr ...... ion-resistant prostate cancer.
@en
Risk factors for febrile neutr ...... ion-resistant prostate cancer.
@nl
type
label
Risk factors for febrile neutr ...... ion-resistant prostate cancer.
@en
Risk factors for febrile neutr ...... ion-resistant prostate cancer.
@nl
prefLabel
Risk factors for febrile neutr ...... ion-resistant prostate cancer.
@en
Risk factors for febrile neutr ...... ion-resistant prostate cancer.
@nl
P2093
P2860
P1476
Risk factors for febrile neutr ...... tion-resistant prostate cancer
@en
P2093
Akira Yokomizo
Ario Takeuchi
Junichi Inokuchi
Katsunori Tatsugami
Keijiro Kiyoshima
Seiji Naito
P2860
P2888
P304
P356
10.1007/S00520-014-2328-7
P577
2014-07-05T00:00:00Z